Is HIF-1α a valid therapeutic target?

Roberto Pili; Ross C. Donehower

doi:10.1093/jnci/95.7.498

Is HIF-1α a valid therapeutic target?

Roberto Pili
, Ross C. Donehower

Medicine

Johns Hopkins University

Research output: Contribution to journal › Editorial

21 Scopus citations

Original language	English
Pages (from-to)	498-499
Number of pages	2
Journal	Journal of the National Cancer Institute
Volume	95
Issue number	7
DOIs	https://doi.org/10.1093/jnci/95.7.498
State	Published - Apr 2 2003

Access to Document

10.1093/jnci/95.7.498

Cite this

@article{b394d69bedda48fc9e2b3a947b5b5393,

title = "Is HIF-1α a valid therapeutic target?",

author = "Roberto Pili and Donehower, \{Ross C.\}",

year = "2003",

month = apr,

day = "2",

doi = "10.1093/jnci/95.7.498",

language = "English",

volume = "95",

pages = "498--499",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",